• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单链Fv抗体片段亲和力对纳米颗粒靶向表皮生长因子受体表达肿瘤细胞的影响。

Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

作者信息

Zhou Yu, Drummond Daryl C, Zou Hao, Hayes Mark E, Adams Gregory P, Kirpotin Dmitri B, Marks James D

机构信息

Department of Anesthesia and Pharmaceutical Chemistry, University of California, San Francisco Rm 3C-38, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110, USA.

出版信息

J Mol Biol. 2007 Aug 24;371(4):934-47. doi: 10.1016/j.jmb.2007.05.011. Epub 2007 May 10.

DOI:10.1016/j.jmb.2007.05.011
PMID:17602702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4198021/
Abstract

To determine the importance of single-chain Fv (scFv) affinity on binding, uptake, and cytotoxicity of tumor-targeting nanoparticles, the affinity of the epidermal growth factor receptor (EGFR) scFv antibody C10 was increased using molecular evolution and yeast display. A library containing scFv mutants was created by error-prone PCR, displayed on the surface of yeast, and higher affinity clones selected by fluorescence activated cell sorting. Ten mutant scFv were identified that had a 3-18-fold improvement in affinity (KD=15-88 nM) for EGFR-expressing A431 tumor cells compared to C10 scFv (KD=264 nM). By combining mutations, higher affinity scFv were generated with KD ranging from 0.9 nM to 10 nM. The highest affinity scFv had a 280-fold higher affinity compared to that of the parental C10 scFv. Immunoliposome nanoparticles (ILs) were prepared using EGFR scFv with a 280-fold range of affinities, and their binding and uptake into EGFR-expressing tumor cells was quantified. At scFv densities greater than 148 scFv/IL, there was no effect of scFv affinity on IL binding and uptake into tumor cells, or on cytotoxicity. At lower scFv densities, there was less uptake and binding for ILs constructed from the very low affinity C10 scFv. The results show the importance of antibody fragment density on nanoparticle uptake, and suggest that engineering ultrahigh affinity scFv may be unnecessary for optimal nanoparticle targeting.

摘要

为了确定单链抗体片段(scFv)亲和力对肿瘤靶向纳米颗粒的结合、摄取及细胞毒性的重要性,利用分子进化和酵母展示技术提高了表皮生长因子受体(EGFR)单链抗体片段C10的亲和力。通过易错PCR构建了一个包含scFv突变体的文库,将其展示在酵母表面,并用荧光激活细胞分选技术筛选出亲和力更高的克隆。与C10单链抗体片段(解离常数KD = 264 nM)相比,鉴定出10个对表达EGFR的A431肿瘤细胞亲和力提高了3至18倍(KD = 15至88 nM)的突变单链抗体片段。通过组合突变,产生了解离常数在0.9 nM至10 nM之间的更高亲和力的单链抗体片段。与亲本C10单链抗体片段相比,亲和力最高的单链抗体片段的亲和力高280倍。使用亲和力范围达280倍的EGFR单链抗体片段制备了免疫脂质体纳米颗粒(IL),并对其与表达EGFR的肿瘤细胞的结合和摄取进行了定量分析。当单链抗体片段密度大于148个单链抗体片段/免疫脂质体时,单链抗体片段亲和力对免疫脂质体与肿瘤细胞的结合、摄取及细胞毒性均无影响。在较低的单链抗体片段密度下,由亲和力极低的C10单链抗体片段构建的免疫脂质体的摄取和结合较少。结果表明抗体片段密度对纳米颗粒摄取的重要性,并提示为实现最佳的纳米颗粒靶向,设计超高亲和力的单链抗体片段可能并无必要。

相似文献

1
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.单链Fv抗体片段亲和力对纳米颗粒靶向表皮生长因子受体表达肿瘤细胞的影响。
J Mol Biol. 2007 Aug 24;371(4):934-47. doi: 10.1016/j.jmb.2007.05.011. Epub 2007 May 10.
2
[Construction and screening of phage antibody libraries against epidermal growth factor receptor and soluble expression of single chain Fv].抗表皮生长因子受体噬菌体抗体文库的构建、筛选及单链抗体的可溶性表达
Yao Xue Xue Bao. 2009 Jun;44(6):597-602.
3
Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.通过结构引导方法对VL框架进行λ到κ的合理置换设计来实现抗EGFR单链抗体片段的稳定性工程。
MAbs. 2015;7(6):1058-71. doi: 10.1080/19420862.2015.1088618. Epub 2015 Sep 4.
4
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.将一种肿瘤靶向性表皮生长因子受体结合亲和体分子定向进化至低纳摩尔亲和力。
J Mol Biol. 2008 Mar 7;376(5):1388-402. doi: 10.1016/j.jmb.2007.12.060. Epub 2008 Jan 4.
5
Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.二价抗ErbB2双抗体片段对肿瘤细胞的靶向作用与抗体的固有亲和力无关。
Cancer Res. 2000 Nov 15;60(22):6434-40.
6
Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.使用¹³¹I标记的抗表皮生长因子受体靶向纳米颗粒进行放射性核素治疗可抑制由表皮生长因子受体(EGFR)过表达引起的癌细胞生长。
J Cancer Res Clin Oncol. 2016 Mar;142(3):619-32. doi: 10.1007/s00432-015-2067-2. Epub 2015 Nov 16.
7
A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy.一种胶原结合型 EGFR 单链 Fv 抗体片段,可用于靶向癌症治疗。
J Control Release. 2015 Jul 10;209:101-9. doi: 10.1016/j.jconrel.2015.04.029. Epub 2015 Apr 24.
8
125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.125I标记的抗表皮生长因子受体-vIII单链Fv对胶质瘤异种移植瘤具有特异性和高水平靶向作用。
Clin Cancer Res. 1999 Jun;5(6):1539-49.
9
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.通过对抗体结合位点中心互补决定区进行分子进化分离出具有皮摩尔亲和力的抗c-erbB-2单链Fv。
J Mol Biol. 1996 Nov 8;263(4):551-67. doi: 10.1006/jmbi.1996.0598.
10
Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.针对表皮生长因子受体(EGFR)的单链抗体在细胞内表达可导致肿瘤细胞生长受抑制。
Oncogene. 1996 Jul 18;13(2):275-82.

引用本文的文献

1
Understanding gold nanoparticles and their attributes in ovarian cancer therapy.了解金纳米颗粒及其在卵巢癌治疗中的特性。
Mol Cancer. 2025 Mar 20;24(1):88. doi: 10.1186/s12943-025-02280-3.
2
Miniaturized Fab' imaging probe derived from a clinical antibody: Characterization and imaging in CRISPRi-attenuated mammary tumor models.源自临床抗体的小型化Fab'成像探针:在CRISPRi减弱的乳腺肿瘤模型中的表征与成像
iScience. 2024 May 24;27(8):110102. doi: 10.1016/j.isci.2024.110102. eCollection 2024 Aug 16.
3
-designed minibinders expand the synthetic biology sensing repertoire.

本文引用的文献

1
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.采用新型脂质体内稳定策略开发高活性纳米脂质体伊立替康。
Cancer Res. 2006 Mar 15;66(6):3271-7. doi: 10.1158/0008-5472.CAN-05-4007.
2
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.通过单链Fv二聚体的亲和力介导增强体内肿瘤靶向性。
Clin Cancer Res. 2006 Mar 1;12(5):1599-605. doi: 10.1158/1078-0432.CCR-05-2217.
3
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.
设计的微型结合蛋白扩展了合成生物学传感功能。
bioRxiv. 2024 Aug 29:2024.01.12.575267. doi: 10.1101/2024.01.12.575267.
4
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications.纳米颗粒介导的癌细胞治疗:从基础科学到临床应用。
Cancer Metastasis Rev. 2023 Sep;42(3):601-627. doi: 10.1007/s10555-023-10086-2. Epub 2023 Feb 24.
5
Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma.表皮生长因子受体特异性嵌合抗原受体T细胞在抑制食管鳞状细胞癌中的作用
Cancers (Basel). 2022 Dec 7;14(24):6021. doi: 10.3390/cancers14246021.
6
Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.针对口腔生物膜的CafA靶向BAR包封纳米颗粒的评估
Pharmaceutics. 2020 Sep 1;12(9):835. doi: 10.3390/pharmaceutics12090835.
7
Nanoparticle-Based Contrast Agents for Xe HyperCEST NMR and MRI Applications.基于纳米颗粒的 Xe 超 CEST NMR 和 MRI 应用对比剂。
Contrast Media Mol Imaging. 2019 Nov 22;2019:9498173. doi: 10.1155/2019/9498173. eCollection 2019.
8
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer.用于向三阴性乳腺癌递送药物的靶向基底膜聚糖的纳米颗粒。
Future Drug Discov. 2019 Jul 1;1(1):FDD8. doi: 10.4155/fdd-2019-0005. eCollection 2019 Jul.
9
Selection and characterization of FcεRI phospho-ITAM specific antibodies.FcεRI磷酸化免疫受体酪氨酸激活基序特异性抗体的筛选与鉴定
MAbs. 2019 Oct;11(7):1206-1218. doi: 10.1080/19420862.2019.1632113. Epub 2019 Jul 16.
10
Ligand Density and Nanoparticle Clustering Cooperate in the Multivalent Amplification of Epidermal Growth Factor Receptor Activation.配体密度和纳米颗粒聚集协同作用于表皮生长因子受体激活的多价放大。
ACS Nano. 2018 Oct 23;12(10):10473-10485. doi: 10.1021/acsnano.8b06141. Epub 2018 Oct 11.
针对体外产生的表皮生长因子受体(EGFR)家族成员细胞外结构域的单链抗体片段(scFvs)的分离。
Cancer Biother Radiopharm. 2005 Dec;20(6):603-13. doi: 10.1089/cbr.2005.20.603.
4
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.表皮生长因子受体靶向免疫脂质体显著增强多种抗癌药物的体内疗效。
Cancer Res. 2005 Dec 15;65(24):11631-8. doi: 10.1158/0008-5472.CAN-05-1093.
5
Glioblastoma multiforme and the epidermal growth factor receptor.多形性胶质母细胞瘤与表皮生长因子受体
N Engl J Med. 2005 Nov 10;353(19):1997-9. doi: 10.1056/NEJMp058186.
6
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.HER2阳性乳腺癌辅助化疗后使用曲妥珠单抗。
N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306.
7
Monoclonal antibody therapy of cancer.癌症的单克隆抗体疗法。
Nat Biotechnol. 2005 Sep;23(9):1147-57. doi: 10.1038/nbt1137.
8
Arming antibodies: prospects and challenges for immunoconjugates.武装抗体:免疫偶联物的前景与挑战
Nat Biotechnol. 2005 Sep;23(9):1137-46. doi: 10.1038/nbt1141.
9
The use of scFv-displaying yeast in mammalian cell surface selections.在哺乳动物细胞表面筛选中使用展示单链抗体片段(scFv)的酵母。
J Immunol Methods. 2005 Sep;304(1-2):30-42. doi: 10.1016/j.jim.2005.05.006.
10
Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.用于A型肉毒杆菌神经毒素灵敏检测的抗体亲和力的分子进化
J Mol Biol. 2005 Aug 5;351(1):158-69. doi: 10.1016/j.jmb.2005.06.003.